European Commission approves Sobi’s Aspaveli for the treatment of C3G and primary IC-MPGN: Stockholm Monday, January 19, 2026, 10:00 Hrs [IST] Sobi, a global biopharma company u ...
Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...
Stablecoins that offer interest-bearing rewards may increasingly resemble bank deposits. But unlike traditional deposits, ...
XRP (CRYPTO: XRP) is increasingly being framed not as a speculative crypto asset, but as a foundational liquidity and ...
How US law legalizes social cleansing. By Chen Qi. The kill line is not merely a gaming metaphor for a poverty threshold; it ...
Many of the limitations people accept as “normal aging” are not inevitable. Muscle health is a primary driver of mobility, ...
Transparency and accountability are cornerstones of trust in government. The U.S. Office of Special Counsel exists to protect ...
Women aren't just being exhausted, they are being failed by systems not designed for them. But leaders like Dr. Niran Al-Agba ...
From Braintree to Project Blueprint, Bryan Johnson views crypto and longevity as a unified war against systemic decay.
Arpan Rai speaks to victims of Grok’s sexualised AI images in India, where there are calls for Elon Musk’s X to do much more ...
Not all human foods are good for dogs; some of them can shut down a dog’s kidneys fast or set off a chain reaction that ends ...
Johnson & Johnson (NYSE: JNJ) today announced positive topline results from the Phase 2b JASMINE (NCT04882878) study of adults living with systemic lupus erythematosus (SLE) and the initiation of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results